Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Targeting Cdc20 as a novel cancer therapeutic strategy.

Targeting Cdc20 as a novel cancer therapeutic strategy. Pharmacol Ther. 2015 Jul; 151:141-51.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.